These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9861496)

  • 41. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
    Ged C; Moreau-Gaudry F; Richard E; Robert-Richard E; de Verneuil H
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):53-60. PubMed ID: 19268002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria.
    Eriksen L; Eriksen N
    Scand J Clin Lab Invest; 1974 Jun; 33(4):323-32. PubMed ID: 4853698
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasmasorbent therapy with activated charcoal column for congenital erythropoietic porphyria.
    Tanigawa K; Namba H; Ohtsuru A; Shima M; Nakata K; Kondo M; Yamashita S; Nagataki S
    Dermatology; 1994; 188(4):329-30. PubMed ID: 8193410
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma porphyrins in the porphyrias.
    Hindmarsh JT; Oliveras L; Greenway DC
    Clin Chem; 1999 Jul; 45(7):1070-6. PubMed ID: 10388484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of ion pair high performance liquid chromatography to the analysis of porphyrins in clinical samples.
    Jacob K; Luppa P
    Biomed Chromatogr; 1991 May; 5(3):122-7. PubMed ID: 1863806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature.
    Shaw PH; Mancini AJ; McConnell JP; Brown D; Kletzel M
    Bone Marrow Transplant; 2001 Jan; 27(1):101-5. PubMed ID: 11244446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital erythropoietic porphyria. A case report with discussion of different porphyrin excretion patterns.
    Dahle JS; Eriksen L; Romslo I; Thune P
    Photodermatol; 1984 Aug; 1(4):187-90. PubMed ID: 6531292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
    Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
    Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital erythropoietic porphyria in two siblings.
    Jacobo A; Almeida HL; Jorge VM
    Dermatol Online J; 2005 Dec; 11(3):15. PubMed ID: 16409911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
    Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Porphyrin studies in congenital erythropoietic porphyria. Studies on a sample of faeces and a sample of urine from a patient with C.E.P. and comparison with a bovine case of this disease.
    Rimington C; With TK
    Dan Med Bull; 1973 Jan; 20(1):5-12. PubMed ID: 4735159
    [No Abstract]   [Full Text] [Related]  

  • 52. Excretion pattern of faecal coproporphyrin isomers I-IV in human porphyrias.
    Jacob K; Doss MO
    Eur J Clin Chem Clin Biochem; 1995 Dec; 33(12):893-901. PubMed ID: 8845420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation.
    Harada FA; Shwayder TA; Desnick RJ; Lim HW
    J Am Acad Dermatol; 2001 Aug; 45(2):279-82. PubMed ID: 11464191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
    Clavero S; Bishop DF; Giger U; Haskins ME; Desnick RJ
    Mol Med; 2010; 16(9-10):381-8. PubMed ID: 20485863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prenatal exclusion of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk.
    Deybach JC; Grandchamp B; Grelier M; Nordmann Y; Boué J; Boué A; de Berrianger P
    Hum Genet; 1980 Feb; 53(2):217-21. PubMed ID: 7358389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Porphyrin studies in chronic renal failure patients on maintenance hemodialysis.
    Anderson CD; Rossi E; Garcia-Webb P
    Photodermatol; 1987 Feb; 4(1):14-22. PubMed ID: 3615245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A plasma porphyrin fluorescence marker for variegate porphyria.
    Poh-Fitzpatrick MB
    Arch Dermatol; 1980 May; 116(5):543-7. PubMed ID: 7377785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria.
    Freesemann AG; Gross U; Bensidhoum M; de Verneuil H; Doss MO
    Eur J Biochem; 1998 Oct; 257(1):149-53. PubMed ID: 9799113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Congenital erythropoietic porphyria].
    Kondo M; Yano Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):152-4. PubMed ID: 9645030
    [No Abstract]   [Full Text] [Related]  

  • 60. Congenital erythropoietic porphyria: clinical, biochemical, and enzymatic profile of a severely affected infant.
    Huang JL; Zaider E; Roth P; Garcia O; Pollack S; Poh-Fitzpatrick MB
    J Am Acad Dermatol; 1996 May; 34(5 Pt 2):924-7. PubMed ID: 8621830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.